Nature Communications (Feb 2017)

An unexpected N-terminal loop in PD-1 dominates binding by nivolumab

  • Shuguang Tan,
  • Hao Zhang,
  • Yan Chai,
  • Hao Song,
  • Zhou Tong,
  • Qihui Wang,
  • Jianxun Qi,
  • Gary Wong,
  • Xiaodong Zhu,
  • William J. Liu,
  • Shan Gao,
  • Zhongfu Wang,
  • Yi Shi,
  • Fuquan Yang,
  • George F. Gao,
  • Jinghua Yan

DOI
https://doi.org/10.1038/ncomms14369
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 10

Abstract

Read online

Programmed cell death 1 (PD-1) is a key target for cancer immunotherapy. Here the authors present the crystal structure of the extracellular PD-1 domain with the clinically approved monoclonal antibody nivolumab, which shows that the N-terminal PD-1 loop is crucial for antibody binding.